Kit for detecting CEBPA gene mutation

A kit and gene technology, applied in the field of kits for detecting CEBPA gene mutations, to achieve the effect of perfecting the genetic diagnosis system
CN101948829AInactive Publication Date: 2011-01-19PEOPLES HOSPITAL PEKING UNIV
1 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN ยท China
Current Assignee / Owner
PEOPLES HOSPITAL PEKING UNIV
Publication Date
2011-01-19
Estimated Expiration
Not applicable ยท inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a kit for detecting CEBPA gene mutation. The invention discloses a special primer composed of primer pairs 1, 2, 3 and 4; primer 1 is composed of DNAs shown as sequence 1 and sequence 2 in a sequence list; the primer pair 2 is composed of DNAs shown as sequence 3 and sequence 4 in the sequence list; primer pair 3 is composed of DNAs shown as sequence 5 and sequence 6 in the sequence list; and primer pair 4 is composed of DNAs shown as sequence 7 and sequence 8 in the sequence list. The invention also provides a special primer containing kit for detecting CEBPA gene mutation. The invention has clinic significance for conventional screening CEBPA gene mutation on AML patients, contributes to further knowing of molecule characteristic of AML patients in China and perfection on gene diagnosis system, is used for more accurate molecular classification, individuation diagnosis and prognosis prediction, thus providing the foundation for selecting appropriate treatment method for patients and having significance on clinic AML diagnosis, layering and prognosis evaluation.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a kit for detecting CEBPA gene mutation. Background technique

[0002] 1. Research overview of molecular markers of acute myeloid leukemia

[0003] Acute myeloid leukemia (AML) is a malignant disease in which the cumulative acquired gene changes of myeloid hematopoietic stem / progenitor cells lead to changes in normal cell proliferation, differentiation and apoptosis pathways. The main types of the disease are complicated in classification, the pathogenesis is still unclear, and they have significant heterogeneity both clinically and genetically. Cytogenetic abnormalities can be identified in approximately 55% of adult AML patients, and approximately 45% of AML patients exhibit a normal karyotype. Recently, a variety of molecular markers with important clinical prognostic value have been identified in AML with normal karyotype. Risk stratification by molecular markers plays an increasingly important role in diagnosis and treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More